{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:16Z","timestamp":1759366516431,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.revmed.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:30:25Z","timestamp":1705998625000},"page":"104-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Argumentaire \u00ab\u00a0en faveur\u00a0\u00bb de la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques autologues dans la scl\u00e9rodermie syst\u00e9mique"],"prefix":"10.1016","volume":"45","author":[{"given":"G.","family":"Pugnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.revmed.2024.01.003_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-021-02548-1","article-title":"Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort","volume":"23","author":"Jaafar","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.revmed.2024.01.003_bib0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0338-4535(75)80004-3","article-title":"Freezing of bone marrow","volume":"18","author":"Gorin","year":"1975","journal-title":"Rev Fr Transfus Immunohematol"},{"key":"10.1016\/j.revmed.2024.01.003_bib0185","first-page":"462","article-title":"H\u00e9matologie et th\u00e9rapie cellulaire. Historique de l\u2019autogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: r\u00f4le actuel en h\u00e9matologie. Nouveaut\u00e9s pour le traitement des leuc\u00e9mies aigu\u00ebs my\u00e9loblastiques de l\u2019adulte","volume":"203","author":"Gorin","year":"2019","journal-title":"Bull Acad Natl Med Vol"},{"issue":"24","key":"10.1016\/j.revmed.2024.01.003_bib0190","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.revmed.2024.01.003_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe fran\u00e7ais du my\u00e9lome","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.revmed.2024.01.003_bib0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704892","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases","volume":"35","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"8020","key":"10.1016\/j.revmed.2024.01.003_bib0205","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(77)91275-2","article-title":"Autologous bone-marrow transplantation in acute myelocytic leukaemia","volume":"1","author":"Gorin","year":"1977","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.revmed.2024.01.003_bib0210","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bmt.1701987","volume":"24","author":"Tyndall","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.revmed.2024.01.003_bib0215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/rheumatology\/36.3.390","article-title":"Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"36","author":"Tyndall","year":"1997","journal-title":"Rheumatology"},{"year":"2022","series-title":"Greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans les maladies auto-immunes","author":"Farge","key":"10.1016\/j.revmed.2024.01.003_bib0220"},{"issue":"10373","key":"10.1016\/j.revmed.2024.01.003_bib0225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.revmed.2024.01.003_bib0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13075-021-02672-y","article-title":"Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality","volume":"23","author":"De Almeida Chaves","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.revmed.2024.01.003_bib0235","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.revmed.2024.01.003_bib0240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.revmed.2024.01.003_bib0245","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40\u00a0years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"24","key":"10.1016\/j.revmed.2024.01.003_bib0250","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van\u00a0Laar","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.revmed.2024.01.003_bib0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"issue":"9790","key":"10.1016\/j.revmed.2024.01.003_bib0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2\u00a0trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.revmed.2024.01.003_bib0265","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2018.01.020","article-title":"Autologous hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis","volume":"24","author":"Shouval","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.revmed.2024.01.003_bib0270","first-page":"CD011819","article-title":"Stem cell transplantation for systemic sclerosis","volume":"7","author":"Bruera","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.revmed.2024.01.003_bib0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.revmed.2024.01.003_bib0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41409-020-0978-2","article-title":"Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5\u00a0days","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.revmed.2024.01.003_bib0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3\u00a0trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"SI","key":"10.1016\/j.revmed.2024.01.003_bib0290","doi-asserted-by":"crossref","first-page":"SI32","DOI":"10.1093\/rheumatology\/keac319","article-title":"Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous hematopoietic stem cell transplantation","volume":"62","author":"Pugnet","year":"2023","journal-title":"Rheumatology"},{"issue":"26","key":"10.1016\/j.revmed.2024.01.003_bib0295","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.revmed.2024.01.003_bib0300","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/kez300","article-title":"Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant\u00a0\u2013\u00a0a systematic review","volume":"59","author":"Puyade","year":"2020","journal-title":"Rheumatology"},{"year":"2017","series-title":"Protocole national de diagnostic et de soins sur la scl\u00e9rodermie syst\u00e9mique","author":"Hachulla","key":"10.1016\/j.revmed.2024.01.003_bib0305"},{"issue":"11","key":"10.1016\/j.revmed.2024.01.003_bib0310","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013\u00a0classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"72","author":"van den\u00a0Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.revmed.2024.01.003_bib0315","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"12S","key":"10.1016\/j.revmed.2024.01.003_bib0320","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bulcan.2017.06.019","article-title":"Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"104","author":"Pugnet","year":"2017","journal-title":"Bull Cancer"},{"issue":"8","key":"10.1016\/j.revmed.2024.01.003_bib0325","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.revmed.2024.01.003_bib0330","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.revmed.2024.01.003_bib0335","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.revmed.2024.01.003_bib0170","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/annrheumdis-2020-217058","article-title":"Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study","volume":"79","author":"van\u00a0Bijnen","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:47:00Z","timestamp":1759337220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0248866324000067"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.01.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Argumentaire \u00ab\u00a0en faveur\u00a0\u00bb de la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques autologues dans la scl\u00e9rodermie syst\u00e9mique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}